Vivos Inc (RDGL)

[Roofus]

We may get FDA approval by the end of this year ….

And possibly as early as Q3.
That is a few months from now, and no later than the next 9 months.

FDA approval would shoot the PPS to at least $3.00 - $6.00 range.
That is a $1 to $2 billion market cap valuation.

From there, if things go well with trials and eventual roll-out, we’re looking at a $7 to $10 billion market cap value at the least.